CNS Logo

Cohen & Steers Inc (CNS) Stock Forecast & Price Prediction

Live CNS Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NYSE | Financial Services | Asset Management

$86.65

-2.55 (-2.86%)

12 Month Price Forecast For CNS

$86.65
Current Price
$4.51B
Market Cap
3 Ratings
Buy 1
Hold 2
Sell 0
Wall St Analyst Ratings

Distance to CNS Price Forecasts

+14.3%
To High Target of $99.00
+6.2%
To Median Target of $92.00
+5.0%
To Low Target of $91.00

CNS Price Momentum

-1.6%
1 Week Change
-6.4%
1 Month Change
+26.1%
1 Year Change
-6.2%
Year-to-Date Change
-21.7%
From 52W High of $110.67
+35.1%
From 52W Low of $64.13

๐Ÿค” Considering Cohen & Steers (CNS)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: January 23, 2025 4:48 AM UTC

CNS Analyst Ratings & Price Targets

Based on our analysis of 6 Wall Street analysts, CNS has a consensus that is neutral. The median price target is $92.00, with forecasts ranging from $91.00 to $99.00. Currently, there are 1 Buy ratings, 2 Hold ratings, and 0 Sell ratings.

With CNS currently trading at $86.65, the median price forecast suggests a 6.2% upside. The most optimistic forecast comes from at , projecting a 14.3% upside, while at provides the most conservative target, suggesting a 5.0% upside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

CNS Analyst Consensus

1
Buy
2
Hold
0
Sell

CNS Price Target Range

Low
$91.00
Average
$92.00
High
$99.00
Current: $86.65

Latest CNS Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for CNS.

Date Firm Analyst Rating Change Price Target
Nov 7, 2024 Evercore ISI Group John Dunn Outperform Maintains $111.00
Oct 17, 2024 UBS Brennan Hawken Neutral Upgrade $102.00
Oct 4, 2024 Evercore ISI Group John Dunn Outperform Maintains $96.00
Sep 5, 2024 Evercore ISI Group John Dunn Outperform Maintains $92.00
Jul 10, 2024 UBS Adam Beatty Sell Maintains $63.00
Apr 12, 2024 UBS Adam Beatty Sell Maintains $67.00
Mar 8, 2024 Evercore ISI Group John Dunn Outperform Maintains $78.00
Jan 10, 2024 UBS Adam Beatty Sell Maintains $69.00
Jan 5, 2024 UBS Adam Beatty Sell Initiates $68.00
Apr 13, 2023 Evercore ISI Group John Dunn Outperform Maintains $68.00
Nov 19, 2020 B of A Securities Michael Carrier Buy Upgrade $76.00
Apr 24, 2020 B of A Securities Neutral Upgrade $0.00
Mar 23, 2020 B of A Securities Michael Carrier Underperform Maintains $34.00
Apr 22, 2019 Gabelli & Co. Hold Downgrade $0.00
Feb 21, 2019 Keefe, Bruyette & Woods Underperform Downgrade $0.00
Feb 21, 2019 Keefe Bruyette & Woods Underperform Downgrade $0.00
Jan 25, 2019 Keefe, Bruyette & Woods Market Perform Upgrade $36.00
Jan 25, 2019 Keefe Bruyette & Woods Market Perform Upgrade $0.00
Jul 20, 2018 Credit Suisse Ari Ghosh Neutral Maintains $41.00
Apr 16, 2018 Gabelli & Co. Buy Upgrade $0.00

Stocks Similar to Cohen & Steers Inc

The following stocks are similar to Cohen & Steers based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Cohen & Steers Inc (CNS) Financial Data

Cohen & Steers Inc has a market capitalization of $4.51B with a P/E ratio of 33.3x. The company generates $496.82M in trailing twelve-month revenue with a 27.2% profit margin.

Revenue growth is +7.7% quarter-over-quarter, while maintaining an operating margin of +33.7% and return on equity of +33.5%.

Valuation Metrics

Market Cap $4.51B
Enterprise Value $4.38B
P/E Ratio 33.3x
PEG Ratio 24.8x
Price/Sales 9.1x

Growth & Margins

Revenue Growth (YoY) +7.7%
Gross Margin +48.7%
Operating Margin +33.7%
Net Margin +27.2%
EPS Growth +23.4%

Financial Health

Cash/Price Ratio +6.7%
Current Ratio 6.0x
Debt/Equity 27.4x
ROE +33.5%
ROA +14.4%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Cohen & Steers Inc logo

Cohen & Steers Inc (CNS) Company Overview

About Cohen & Steers Inc

What They Do

Asset management firm specializing in real assets.

Business Model

The company operates as an asset management holding firm, providing tailored investment solutions for institutional investors such as pension funds, endowments, and foundations. It generates revenue by managing a diverse range of portfolios, including equity, fixed income, and multi-asset mutual funds, as well as hedge funds, charging management and performance fees.

Additional Information

Founded in 1986 and headquartered in New York, the firm focuses on real assets and alternative income strategies, investing in sectors such as real estate, infrastructure, and natural energy resources. It is recognized as a leading global investment manager in its niche market.

Company Information

Sector

Financial Services

Industry

Asset Management

Employees

405

CEO

Mr. Joseph Martin Harvey

Country

United States

IPO Year

2004

Cohen & Steers Inc (CNS) Latest News & Analysis

CNS stock latest news image
Quick Summary

Cohen & Steers Income Opportunities REIT, Inc. has acquired Oak Grove Shoppes in Orlando, FL, in a joint venture with Phillips Edison & Company, targeting $300M in equity for grocery-anchored centers.

Why It Matters

CNSREIT's acquisition of Oak Grove Shoppes signals growth and strategic investment in grocery-anchored properties, potentially enhancing revenue and stability for investors.

Source: PRNewsWire
Market Sentiment: Neutral
CNS stock latest news image
Quick Summary

Cohen & Steers, Inc. (NYSE: CNS) will release its Q4 and full year 2024 results on January 22, 2025, after market close. Details will be available on its investor relations website.

Why It Matters

Cohen & Steers' upcoming earnings release may impact stock performance and investor sentiment, providing insights into financial health and future growth potential.

Source: PRNewsWire
Market Sentiment: Neutral
CNS stock latest news image
Quick Summary

Cohen & Steers, Inc. (NYSE: CNS) reported preliminary AUM of $85.8 billion as of Dec 31, 2024, down $5.6 billion from Nov 30, 2024, due to market depreciation and distributions, despite net inflows.

Why It Matters

Cohen & Steers' decline in assets under management signals potential challenges in market performance and investor sentiment, impacting future revenue and growth prospects.

Source: PRNewsWire
Market Sentiment: Neutral
CNS stock latest news image
Quick Summary

Cohen & Steers Income Opportunities REIT, Inc. has acquired Bridgepointe Shopping Center in San Mateo, CA, through a joint venture with Sterling Organization, marking its fourth open-air center purchase.

Why It Matters

CNSREIT's acquisition of Bridgepointe Shopping Center signals growth and strategic partnerships, enhancing its portfolio and potential income, impacting investor confidence and stock performance.

Source: PRNewsWire
Market Sentiment: Neutral
CNS stock latest news image
Quick Summary

Cohen & Steers Closed-End Funds announced Q1 2025 monthly distributions: FOF $0.087, LDP $0.131, PSF $0.126, PTA $0.134, RFI $0.080, RLTY $0.110, RNP $0.136, RQI $0.080, UTF $0.155.

Why It Matters

Cohen & Steers' announcement of monthly distributions signals potential income stability for investors, impacting cash flow expectations and portfolio strategies for income-focused strategies.

Source: PRNewsWire
Market Sentiment: Neutral
CNS stock latest news image
Quick Summary

Cohen & Steers, Inc. (NYSE: CNS) appointed Jon Cheigh as President, effective January 1, 2025. He will also retain his role as Chief Investment Officer.

Why It Matters

The appointment of Jon Cheigh as President signals a potential shift in leadership strategy at Cohen & Steers, possibly impacting investment performance and company direction.

Source: PRNewsWire
Market Sentiment: Neutral

Frequently Asked Questions About CNS Stock

What is Cohen & Steers Inc's (CNS) stock forecast for 2025?

Based on our analysis of 6 Wall Street analysts, Cohen & Steers Inc (CNS) has a median price target of $92.00. The highest price target is $99.00 and the lowest is $91.00.

Is CNS stock a good investment in 2025?

According to current analyst ratings, CNS has 1 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $86.65. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for CNS stock?

Wall Street analysts predict CNS stock could reach $92.00 in the next 12 months. This represents a 6.2% increase from the current price of $86.65. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Cohen & Steers Inc's business model?

The company operates as an asset management holding firm, providing tailored investment solutions for institutional investors such as pension funds, endowments, and foundations. It generates revenue by managing a diverse range of portfolios, including equity, fixed income, and multi-asset mutual funds, as well as hedge funds, charging management and performance fees.

What is the highest forecasted price for CNS Cohen & Steers Inc?

The highest price target for CNS is $99.00 from at , which represents a 14.3% increase from the current price of $86.65.

What is the lowest forecasted price for CNS Cohen & Steers Inc?

The lowest price target for CNS is $91.00 from at , which represents a 5.0% increase from the current price of $86.65.

What is the overall CNS consensus from analysts for Cohen & Steers Inc?

The overall analyst consensus for CNS is neutral. Out of 6 Wall Street analysts, 1 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $92.00.

How accurate are CNS stock price projections?

Stock price projections, including those for Cohen & Steers Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.